Evidence map›Paper›PMID 31512606›Full record

ArticleInternational journal of mycobacteriology

Competitive fitness of

Ousmane Kodio, Antieme Combo Georges Togo, Yeya Dit Sadio Sarro, Bintou Fane, Fatimata Diallo, Amadou Somboro, Boureima Degoga, Mahamadou Kone, Gagni Coulibaly, Mohamed Tolofoudje and 13 more

Abstract read
In one paragraph

Article in International journal of mycobacteriology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Reduced fitness and enhanced immunogenicity ofCurrent research in microbial sciences · 2025
    Article
  3. Review
  4. Genomic Characterization of Drug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Horizontal Transfer of DifferentFrontiers in microbiology · 2021
    Article
  8. Review
  9. Frontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ousmane KodioUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako; National Health Laboratory, Ministry of Health and Social Affairs, Bamako, Mali.
Antieme Combo Georges TogoUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Yeya Dit Sadio SarroUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Bintou FaneUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Fatimata DialloUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Amadou SomboroUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Boureima DegogaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Mahamadou KoneUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Gagni CoulibalyUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Mohamed TolofoudjeUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Sidy BaneUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Moumine SanogoUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Bourahima KoneUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Nadie CoulibalyUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Djeneba DabitaoUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Bocar BayaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Mamoudou MaigaCenter for Innovation in Global Health Technologies, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Flabou BougoudogoNational Institute of Public Health Research, Ministry of Health and Social Affairs, Bamako, Mali.
Fasse SamakeMicrobial Biotechnology Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Sounkalo DaoUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Seydou DoumbiaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Souleymane DialloUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Bassirou DiarraUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Funding

HIV and Mycobacterial Disease in MaliD43TW010350 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI MAIGA, ALMOUSTAPHA ISSIAKA, MURPHY, ROBERT LEO · 2016 to 2025
$3.0M
Host-Pathogen Interactions in a Failing Global lineage of MTBC:M.africanumR01AI110386 · NIAID · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DIALLO, SOULEYMANE · 2014 to 2018
$1.2M
Strengthening Guinea-Mali Collaborative Training and Research Network for a Better Control of Emerging Viral DiseasesD71TW010428 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI BEAVOGUI, ABDOUL HABIB, DIARRA, BASSIROU · 2017 to 2017
$50k
FIC NIH HHS D43 TW010350FIC NIH HHS D71 TW010428NIAID NIH HHS R01 AI110386
6 · The paper itself

Abstract

Background: While, bacteria resistance mutations can affect competitive fitness, given our multidrug-resistant (MDR) prevalence, we conducted this study to determine the impact of MDR on the competitive fitness of Mycobacterium tuberculosis (MTB) complex MDR strains. We conducted a cross-sectional study at the University Clinical Research Center (UCRC) from January to December 2017. New TB patients over aged of 18 were recruited at University teaching hospital and health reference centers of Bamako in USTTB Ethical committee approved protocols. Methods: MDR and drug-susceptible (wild-type [WT]) MTB strains (T1 and Beijing) and MTB H37Rv were competed on solid media in UCRC's Tuberculosis Laboratory. Competitive and individual cultures were incubated for 14 days at 37°C with 7% CO2. Number of generation, generation time, and relative competitive fitness (W) of the strains were calculated. Data were analyzed with Epi-Info 7.1.5.2 software (CDC). P value was considered significant when it was <0.05. Scientific calculator (CS-82TL) was used for competitive fitness parameters calculations. Results: We performed 24 competitive cultures and 10 individual cultures. In individual cultures, strains' generation number was for Beijing (WT: 4.60 and mutant MR: 4.40), T1 (WT: 2.69 and MR: 2.37), and H37Rv: 2.91. Generation number of WT strains was less than those of MDR strains in both individual and competitive culture. Relative competitive fitness was below 1 (W<1) in 83.3%. Conclusion: MDR strains were less competitive than WT strains in 83.3% of cases. Resistant mutation impacts bacteria fitness.

Indexed as

Genetic FitnessMutationAntitubercular AgentsDrug Resistance, Multiple, BacterialGenotypeHumansMaliMycobacterium tuberculosisProspective StudiesTuberculosis, Multidrug-ResistantAntitubercular AgentsCost of resistancein vitro competitionMaliMycobacterium tuberculosis-multidrug-resistant

Identifiers

PMID31512606
PMCPMC6918047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.